| P50 | author | Hugh A Sampson | Q65559603 |
| P2093 | author name string | Justin M Skripak | |
| P2860 | cites work | Effect of anti-IgE therapy in patients with peanut allergy | Q28183354 |
| | Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract1 | Q28243179 |
| | IL-21 induces inhibitor of differentiation 2 and leads to complete abrogation of anaphylaxis in mice | Q28259769 |
| | Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas | Q28263136 |
| | A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy | Q28307175 |
| | Production of Recombinant Peanut Allergen Ara h 2 using Lactococcus lactis. | Q36025631 |
| | Peanut allergy: emerging concepts and approaches for an apparent epidemic | Q36906296 |
| | Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System | Q37060819 |
| | Paediatric anaphylaxis: a 5 year retrospective review. | Q37240083 |
| | Pharmacological and immunological effects of individual herbs in the Food Allergy Herbal Formula-2 (FAHF-2) on peanut allergy | Q40106452 |
| | Allergenic characteristics of a modified peanut allergen | Q40367856 |
| | Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). | Q40417255 |
| | Treatment of peanut allergy with rush immunotherapy | Q41111237 |
| | Role of conformational and linear epitopes in the achievement of tolerance in cow's milk allergy | Q43778339 |
| | Oral desensitizing treatment in food allergy: clinical and immunological results | Q44299630 |
| | Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy | Q44504353 |
| | The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy | Q45215097 |
| | Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? | Q45356054 |
| | A novel druglike spleen tyrosine kinase binder prevents anaphylactic shock when administered orally | Q46551677 |
| | Severe food-allergic reactions in children across the UK and Ireland, 1998-2000. | Q46724254 |
| | A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases | Q46940706 |
| | Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. | Q46941018 |
| | Avirulant Salmonella typhimurium strains prevent food allergy in mice. | Q50065059 |
| | Egg oral immunotherapy in nonanaphylactic children with egg allergy. | Q50702311 |
| | Tolerance to extensively heated milk in children with cow's milk allergy. | Q50779129 |
| | Food allergy in children: results of a standardized protocol for oral desensitization. | Q50903608 |
| | Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. | Q50994741 |
| | Disruption of T-cell immunoglobulin and mucin domain molecule (TIM)-1/TIM4 interaction as a therapeutic strategy in a dendritic cell-induced peanut allergy model. | Q52587435 |
| | Oral specific desensitization in food-allergic children. | Q52676121 |
| | Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula-2 is associated with up-regulation of interferon-gamma. | Q53551457 |
| | Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells | Q56901784 |
| | Specific oral tolerance induction in children with very severe cow's milk–induced reactions | Q57243160 |
| | Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction | Q66829364 |
| | Allergenic activity of heated and ovomucoid-depleted egg white | Q73635549 |
| | Food allergy is a matter of geography after all: sesame as a major cause of severe IgE-mediated food allergic reactions among infants and young children in Israel | Q77799300 |
| | Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization | Q79816131 |
| | Oral desensitization in children with milk and egg allergies obtains recovery in a significant proportion of cases. A randomized study in 60 children with cow's milk allergy and 90 children with egg allergy | Q80000963 |
| | Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice | Q80126897 |
| | A synthetic triacylated pseudo-dipeptide molecule promotes Th1/TReg immune responses and enhances tolerance induction via the sublingual route | Q80156066 |
| | Successful oral desensitization for systemic peanut allergy | Q80178587 |
| | Sublingual immunotherapy for cow's milk protein allergy: a preliminary report | Q80190729 |
| | Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents | Q80505534 |
| | Oral administration of a synthetic agonist of Toll-like receptor 9 potently modulates peanut-induced allergy in mice | Q80508059 |
| | Orally administered TGF-beta is biologically active in the intestinal mucosa and enhances oral tolerance | Q80556807 |
| | IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model | Q81235051 |
| | Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract | Q81454014 |
| | Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually | Q81540648 |
| | Rush oral immunotherapy in children with persistent cow's milk allergy | Q81583734 |
| | Comparative analysis of nasal and oral mucosa dendritic cells | Q82247193 |
| | Oral rush desensitization in peanut allergy: a case report | Q83155181 |
| P433 | issue | 6 | |
| P304 | page(s) | 690-696 | |
| P577 | publication date | 2008-10-23 | |
| P1433 | published in | Current Opinion in Immunology | Q15752917 |
| P1476 | title | Towards a cure for food allergy | |
| P478 | volume | 20 | |